September 20, 2017 IRVINE, Calif.–(BUSINESS WIRE)–Irvine, California-based Biogennix, an osteobiologic company which develops, manufactures, and distributes proprietary bone graft substitutes used for bone fusion procedures, announced today that its products have now been used in more than 6000 patients. The company’s novel bone graft substitutes, osteoSPAN™ and Morpheus™ are resorbable, […]